Roche seeks partner to take over plant, produce key antibiotic
After manufacturing the antibiotic Rocephin for four decades—and developing it into one of the company’s first blockbuster medicines—Roche…
Novartis misses quarterly sales, profit estimates as Entresto generics hit growth
SWISS drugmaker Novartis reported first-quarter core operating profit and sales below market expectations on Tuesday, as generic competition…
Novartis’ new drugs outweigh Entresto decline in Q3
Novartis’ third-quarter results have exemplified the reason for its recent deal-making activity, as heart failure therapy Entresto finally…